Sofgen Pharma S.A. (PRCWF) — 6-K Filings

All 6-K filings from Sofgen Pharma S.A.. Browse 34 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (34)

6-K Filing — Dec 5, 2025
6-K Filing — Nov 19, 2025
Procaps Group CEO Departs — Aug 1, 2025 Risk: medium
Procaps Group, S.A. announced on July 25, 2025, that Dr. Camilo Camacho has been relieved of his duties as Interim Co-Chief Executive Officer. The company is a
Procaps Group Appoints New Directors to Board and Committees — Jul 14, 2025 Risk: low
On July 14, 2025, Procaps Group, S.A. announced the appointment of Mr. Fernando Moreira Muniz and Mr. Carlos Romero to its Board of Directors. These appointment
Procaps Group Appoints Two New Directors to Board — May 13, 2025 Risk: low
On May 8, 2025, Procaps Group, S.A. appointed Mr. Carlos Garcia Iragorri and Mr. Manuel Vial as new Directors to its Board. These appointments were made to fill
Procaps Group Announces Private Share Offering — Apr 14, 2025 Risk: medium
Procaps Group, S.A. announced on March 24, 2025, that its Board of Directors approved a private offering of its ordinary shares to accredited investors. This of
Procaps Group Raises $130M, Restructures Debt — Apr 9, 2025 Risk: medium
On April 9, 2025, Procaps Group, S.A. announced the successful completion of a $130 million capital raise, which included secured convertible notes issued to Ho
Procaps Group Shareholders Approve All Matters at Extraordinary Meeting — Mar 25, 2025 Risk: low
Procaps Group, S.A. held an extraordinary general meeting of shareholders on March 24, 2025, where all submitted matters were approved. The company is a foreign
Procaps Group Sets Shareholder Meeting for March 24 — Mar 6, 2025 Risk: low
Procaps Group, S.A. announced on March 5, 2025, that its extraordinary general meeting of shareholders will take place on March 24, 2025. Shareholders of record
Procaps Group Schedules Extraordinary Shareholder Meeting — Feb 19, 2025 Risk: low
Procaps Group, S.A. announced on February 19, 2025, that an extraordinary general meeting of shareholders will be held on March 7, 2025. The record date for det
Procaps Appoints Interim Co-CEOs Amid CEO Departure — Feb 3, 2025 Risk: medium
Procaps Group, S.A. announced on January 29, 2025, the appointment of Ms. Melissa Angelini and Dr. Camilo Camacho as Interim Co-Chief Executive Officers. This c
Procaps Group Director Jose Minski Resigns — Jan 21, 2025 Risk: low
Procaps Group, S.A. announced on January 17, 2025, that Jose Minski has resigned as a Director of the Board. His resignation is effective upon the appointment o
Procaps Group Appoints New Director and Audit Committee Member — Jan 16, 2025 Risk: low
On January 10, 2025, Procaps Group, S.A. appointed Mr. Jorddy Antonio Pérez to its Board of Directors and as a member of the Audit Committee. Mr. Pérez has also
Procaps Group Faces Nasdaq Delinquency Over Financial Filings — Jan 3, 2025 Risk: medium
Procaps Group, S.A. received a delinquency letter from Nasdaq on December 31, 2024, for failing to file its interim financial statements as required by Listing
Procaps Group Appoints Interim CFO for Financial Restatement — Dec 31, 2024 Risk: medium
Procaps Group, S.A. announced on December 27, 2024, that its Board of Directors appointed an Interim Chief Financial Officer, effective December 19, 2024. This
Procaps Group Holds Shareholder Meetings — Dec 20, 2024 Risk: low
On December 16, 2024, Procaps Group, S.A. held both an extraordinary general meeting and an annual general meeting of shareholders. Shareholders approved and ad
Procaps Group Plans Up to $100M Private Offering — Dec 3, 2024 Risk: medium
Procaps Group, S.A. announced on November 27, 2024, that its Board of Directors approved a private offering of up to $100 million in securities. This offering i
Procaps Group Schedules Shareholder Meetings for Dec 16 — Nov 29, 2024 Risk: low
Procaps Group, S.A. announced on November 29, 2024, that its extraordinary and annual general meetings of shareholders will take place on December 16, 2024, at
Procaps Group Faces Nasdaq Delinquency Over Unfiled 20-F Report — Nov 15, 2024 Risk: medium
Procaps Group, S.A. filed a Form 6-K on November 15, 2024, reporting a delinquency letter received from Nasdaq on May 16, 2024. The letter indicated the company
Procaps Group Appoints New Director to Board — Nov 1, 2024 Risk: low
On October 28, 2024, Procaps Group, S.A. appointed Roberto Albisetti as a Director to its Board and as a member of the M&A Committee. This appointment is part o
Procaps Group to Restate Financials After Investigation — Oct 10, 2024 Risk: medium
Procaps Group, S.A. announced on October 10, 2024, that it will restate its previously issued financial statements. This decision follows an independent investi
Procaps Group Director Resigns — Oct 8, 2024 Risk: low
On October 8, 2024, Ruben Minski resigned from the Board of Directors of Procaps Group, S.A. The company is currently evaluating potential successors for his po
Procaps Group Issues $5M Subordinated Note to Minski Family Entity — Sep 18, 2024 Risk: medium
On September 12, 2024, Procaps Group, S.A. issued a $5.0 million junior unsecured subordinated promissory note to Olvi Investment Limited. Olvi Investment Limit
Procaps Group S.A. CEO Outlines Strategic Priorities — Sep 3, 2024 Risk: low
On September 3, 2024, Procaps Group, S.A. issued a press release detailing the current state of its business and outlining key strategic priorities. The press r
Procaps Group Secures Forbearance on $195M Debt — Aug 26, 2024 Risk: medium
On August 25 and 26, 2024, Procaps Group, S.A. and its subsidiaries entered into forbearance agreements with creditors concerning approximately $195 million in
Procaps Group Updates on Internal Accounting Investigation — Jul 10, 2024 Risk: medium
Procaps Group, S.A. filed a 6-K on July 10, 2024, providing an update on its ongoing internal investigation initiated by the Audit Committee. The investigation
Procaps Group Appoints New Chairman of the Board — Jun 28, 2024 Risk: low
Procaps Group, S.A. announced on June 28, 2024, that Jose Minski will become the new Chairman of the Board of Directors, effective June 30, 2024. He will succee
Procaps Group Receives Nasdaq Delinquency Notice — May 20, 2024 Risk: medium
On May 16, 2024, Procaps Group, S.A. received a delinquency letter from Nasdaq because it had not yet filed its Annual Report on Form 20-F for the year ended De
Procaps Group Delays 2023 20-F Filing — May 14, 2024 Risk: medium
Procaps Group, S.A. announced on May 14, 2024, that it will be unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, by the
Procaps Group Delays 2023 Financial Filings — May 1, 2024 Risk: medium
Procaps Group, S.A. announced on May 1, 2024, that it is delaying the preparation of its financial statements and the filing of its 20-F for the year ended Dece
Procaps Group Forms Strategic Committee for Value Creation — Mar 4, 2024 Risk: low
On March 4, 2024, Procaps Group, S.A. announced the formation of a strategic committee. This committee is tasked with exploring initiatives aimed at creating va
Procaps Shareholders Re-Elect Entire Board, Rejecting Revocation Bid — Jan 24, 2024
Procaps Group, S.A. held a general meeting of shareholders on January 22, 2024, where they rejected a proposal to revoke all current board members. Instead, sha
Procaps Group: Incorrect Voting Instructions for Jan 22 Shareholder Meeting — Jan 16, 2024
Procaps Group, S.A. (NASDAQ: PROCS) issued a 6-K filing on January 16, 2024, to inform shareholders that incorrect online voting instructions were provided for
Procaps Group Sets Jan 22 Shareholder Meeting; Jan 5 Record Date — Jan 5, 2024
Procaps Group, S.A. announced on January 5, 2024, that a general meeting of shareholders will be held on Friday, January 22, 2024, at 3:00 p.m. Luxembourg time.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX